Generic Drugs Marketing Pharma Companies Production 
Pharmaceutical Technology
MARCH 22, 2023
During the pandemic, the shortage of basic drugs such as paracetamol in key EU countries led to growing calls to push local drug manufacturing to ensure a smooth supply and to minimise shortages. Despite having large biopharmaceutical companies on home ground, the UK and France experienced major shortages and supply chain issues.
Creogenic Pharma
APRIL 15, 2023
1* Pharma Franchise Company Submit Lowest Price 250+ Products Best Service Best Quality Just a few decades ago Baddi was a town of dust. The land was dull and there were next to zero companies there. We have a vast network of customers throughout the nation who trust us for our quality and affordable products.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
AUGUST 22, 2023
Claire D’Abreau-Hayling, Chief Scientific Officer at Sandoz, examines how generic products can relieve industry pressure and improve access to essential medicines. Off-patent medicines today account for about 80% of global prescriptions at an estimated 20% of the total cost. What are complex generics?
Pharmaceutical Technology
DECEMBER 15, 2022
Inflation at its current levels poses a major threat to generics production and usage. Since the summer, generics makers have been signalling that additional support for help with rising costs is required to keep generics production viable. Inflation can damage production viability of European drugs.
Pharmaceutical Technology
JULY 15, 2022
Nothing epitomises market failures more than the cost of insulin,” Newsom said in a video posted on Twitter. California’s budget documents give few details about the tender process, but state that CalRx will spend $50 million to partner with a contract manufacturer to develop biosimilar insulin products in vial and pen form.
World of DTC Marketing
APRIL 12, 2021
QUICK READ: Pharma supply chain issues are a concern for us all but especially patients. The goal of getting a drug to market as fast as possible so they can recoup drug development costs has the potential for mistakes that could cost lives. Why would a pharma company take risks like these?
Pharmaceutical Technology
SEPTEMBER 23, 2022
For pharma and biotech companies, there are many advantages to partnering with a Contract Development and Manufacturing Organisations (CDMO): they can access more specialized knowledge, state-of-the-art equipment, and qualified staff, as well as reduce their total cost of ownership, all while maintaining speed to market.
Expert insights. Personalized for you.
263 
Let's personalize your content